Yantai Dongcheng Biochemicals Co.’s (Yantai, China) chondroitin sulfate has received a Certificate of Suitability (COS) from the European Directorate for the Quality of Medicines & Healthcare. The certificate indicates that the chondroitin sulfate complies with European Pharmacopeia standards.
Yantai Dongcheng Biochemicals Co.’s (Yantai, China) chondroitin sulfate has received a Certificate of Suitability (COS) from the European Directorate for the Quality of Medicines & Healthcare. The certificate indicates that the chondroitin sulfate complies with European Pharmacopeia standards.
The announcement was made by chondroitin sulfate supplier Pacific Rainbow International (City of Industry, CA), which owns 21.67% of Dongcheng’s facility and handles its marketing in the United States.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.